bmb chemical biology hero illustration 2.jpg
Page Menu

Chemical Biology

What is Chemical Biology?

Researchers in chemical biology use the power of chemistry to explore fundamental biological processes in new and exciting ways. In our department, chemical biologists are discovering new treatments to thwart the impacts of diseases like COVID-19, ALS, HIV, and cancer.

Chemistry is a central pillar of our department’s mission. As such, we have a program completely dedicated to it! Run by Dr. Paul Thompson, The Program in Chemical Biology (PCB) unites scientists across UMass Chan in their mission to tackle important biological questions using the tools of chemistry.

What is the impact of our research in Chemical Biology?

  • Drug delivery may be improved by nanotechnology designed and tested in our department. Find out more here.
  • Ion channel research is furthered by the development and implementation of new chemical probes in our department. Understanding ion channel biology is critical to the development of new treatments for diseases like cardiac arrhythmia, hearing loss, and much more. Find out more on the Kobertz Lab site.
  • New therapies for autoimmune diseases are being discovered by chemists in our department. Find out more here.

 

Who's studying Chemical Biology?

  • Akbar Ali

    Akbar Ali , PhD

    Associate Professor of Biochemistry & Molecular Biotechnology; Director of the Synthetic Chemistry Facility; Manager of the Small Molecule NMR Facility; Member of the Schiffer Lab
  • Gang Han

    Gang Han , PhD

    Professor of Biochemistry & Molecular Biotechnology
  • William R. Kobertz

    William R. Kobertz , PhD

    Professor Biochemistry & Molecular Biotechnology
  • Stephen Miller

    Stephen Miller , PhD

    Professor of Biochemistry & Molecular Biotechnology
  • William E. Royer

    William E. Royer , PhD

    Professor Emeritus of Biochemistry & Molecular Biotechnology
  • Celia Schiffer

    Celia Schiffer , PhD

    Chair & Arthur F. and Helen P. Koskinas Professor of Biochemistry and Molecular Biotechnology, and Director of the Institute for Drug Resistance
  • Paul Thompson

    Paul Thompson , PhD

    Endowed Chair in Biochemistry and Molecular Biotechnology II; Director of the Program in Chemical Biology; Professor of Biochemistry & Molecular Biotechnology
  • Qing Yu

    Qing Yu , PhD

    Assistant Professor of Biochemistry & Molecular Biotechnology

x


x

Relevant Blog Posts

  • bmb blog resized celia nas.png

    Dr. Celia Schiffer elected to the National Academy of Sciences

    Breaking news! Dr. Celia Schiffer, the Chair and the Arthur F. and Helen P. Koskinas Professor of Biochemistry & Molecular Biotechnology, and the Director of the Institute for Drug Resistance, was elected to the National Academy of Sciences!

    Read more
  • albert sherman glowing in the night

    New NMR machine to initiate New England NMR Consortium

    BMB department faculty members Dr. Francesca Massi & Dr. Celia Schiffer, alongside Dr. Jasna Fejzo at UMass AMherst, were awarded a grant from the Massachusetts Life Science Center to purchase a brand new NMR machine! Find out why this is a big deal and how it might change the face of scientific research at UMass Chan Medical School.

    Read more
  • bmb blog resized sting.png

    Taking the STING out of Disease -Biochemistry & Molecular Biotechnology (BMB) Department

    Dr. Paul Thompson of the Biochemistry & Molecular Biotechnology department at UMass Chan Medical School recently published a newly discovered inhibitor of STING signaling that could be a promising new treatment option for various diseases including lupus, SAVI, and ALS.

    Read more
  • bmb blog resized cobratoxins.png

    St. Patrick's Day, Snakes and biochemiStry!

    Happy St. Patrick's Day! Join us to learn about the biochemistry of snake venoms, and how they might be used to treat a variety of human diseases!

    Read more
  • bmb blog resized PAD.png

    BMB highlights research on PAD enzymes for Autoimmune Disease Awareness Month

    For Autoimmune Disease Awareness Month, we are featuring the work of Dr. Paul Thompson in our department. The goal of his research is to develop drugs to inhibit a family of proteins called PAD's that play a major role in the pathology of many different autoimmune diseases.

    Read more
  • bmb blog resized covid19.png

    Coming up with new ways to treat COVID-19 is at the *heart* of BMB.

    #newscience alert! Several groups in our department collaborated to characterize coronavirus proteases and compounds that could be used to inhibit them to prevent future outbreaks. In this special Valentine's Day post, you'll find highlights from these two publications and beautiful representations of a coronavirus protease that looks like a heart. We love biochemistry!

    Read more

Molecular illustrations on this webpage were generated by Leonora Martínez-Núñez, PhD.